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Abstract: Unlike their isocyano and isothiocyanato analogues, 
isocyanato esters remain almost unexplored as formal 1,3-dipoles in 
asymmetric catalytic reactions. In this communication, the first 
asymmetric formal [3+2] cycloaddition involving isocyanato esters 
and electrophilic alkenes is reported. Diisopropyl 2-
isocyanatomalonate reacts with α,β-unsaturated N-(o-anisidyl) 
imines in the presence of a Mg(OTf)2-BOX complex to give highly 
substituted chiral pyrrolidinones featuring a conjugate exocyclic 
double bond with excellent yields and enantiomeric excesses up to 
99%. Several transformations of the resulting heterocycles, including 
the synthesis of a pyroglutamic acid derivative have been carried out. 
Pyrrolidinones (-lactams) and, in particular, 2-
alkoxycarbonylpyrrolidinones (pyroglutamic acid derivatives) 
have been extensively used as building blocks in synthetic 
chemistry[1] and as chiral ligands in asymmetric catalysis.[2] They 
are also structural units frequently encountered in numerous 
biologically active natural products and pharmaceuticals (Figure 
1). Examples include the marine metabolite (-) salinosporamide 
A, currently tested as an anticancer drug candidate,[3] the 
proteasome inhibitors antiprotealide and lactacystin,[4] the 
antibiotic and antitumoral compound neooxazolmycin, isolated 
form a strain of Streptomyces,[5] the neuroexcitotoxic dysibetaine, 
isolated from the Micronesian sponge Dysidea herbacea,[6] or 
the lipooligosaccharides found in the cell wall of different 
mycobacteria.[7]  
Given the widespread chemical significance of these 
scaffolds, the development of new efficient and atom economy 
processes for the construction of these heterocyclic systems, 
especially in an enantioselective manner, constitutes an 
important challenge in current organic synthesis. Besides 
procedures based on the structural modification of nitrogen-
containing heterocycles such as pyrrolidinones, pyroglutamic 
acid or succinimides,[8] cyclization procedures in which the 
pyrrolidinone heterocycle is formed from acyclic precursors 
result especially appealing. The Michael addition/lactamization 
reaction of 2-amino acids and unsaturated acid derivatives is 
one of the first used procedures for the synthesis of -lactams.[9] 
Recently, the double Michael addition of amide-tethered diacids 
with alkynones[10] and the Conia-ene reaction of alkynyl 
amidomalonates[11] have been used in the synthesis of 
pyroglutamic acid derivatives. However, most of the methods for 
the enantioselective synthesis of pyrrolidinones are still based 
on chiral starting materials or stoichiometric reagents,[12] and 
only few asymmetric catalytic procedures are available. Among 
them, enantioselective versions of the Michael 
addition/lactamization reaction of 2-amino acids and unsaturated 
acid derivatives have been reported by several groups.[13] Chiral 
-lactams have been obtained with excellent enantioselectivities 
via N-heterocyclic carbene catalyzed coupling of imines with 
unsaturated aldehydes.[14] Finally, the reaction between 2-
aminomalonates and Morita-Baylis-Hillman carbonates 
catalyzed by chiral Lewis bases to give -methylene--lactams 
with moderate enantioselectivity has been recently reported.[15]  
 
Figure 1. Examples of bioactive natural compounds incorporating a 
pyrrolidinone unit. 
On the other hand, 2-isocyano-[16] and 2-isothiocyanato[17] 
esters have been increasingly used as formal 1,3-dipoles in 
asymmetric synthesis over the last years. These compounds 
react with different unsaturated groups to give a variety of five-
membered nitrogen-containing heterocycles. In particular, their 
participation in asymmetric catalytic formal [3+2] cycloaddition 
reactions with conjugate carbonyl compounds has provided a 
strightforward access to enantiomerically enriched pyrrolidines[18] 
or thiopyrrolidinones,[19] respectively (Scheme 1). Following 
these antecedents, we envisaged that a formal [3+2] 
cycloaddition between a 2-isocyanato esters and a proper 
Michael acceptor may be used for the efficient and atom-
economy enantioselective synthesis of 2-
alkoxycarbonylpyrrolidinones (Scheme 1). However, the use of 
2-isocyanato esters in reactions that combine both nucleophilic 
and electrophilic behavior (1,3-dipole-like behavior) is 
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challenging due to the higher reactivity of the isocyanate group 
compared to the isocyano and isothiocyanate groups. In fact, 2-
isocyanato esters have been mainly used as electrophiles for 
the preparation of ureas and carbamates,[20] while reactions 
making use of their 1,3-dipole-like character are almost inknown. 
To the best of our knowledge, the organocatalytic reaction of 2-
isocyanatomalonate esters and aldehydes to give 
oxazolidinones developed by Takemoto,[21] is the only example 
reported in the literature, so far.[22] Following our research on the 
use of 1-aza-butadienes as electrophiles,[23] we report here the 
first example of enantioselective formal [3+2] cycloaddition of 2-
isocyanato esters with alkenes to give highly substituted α,β-
unsaturated -lactams. The reaction is carried out by using 
unsaturated imines, 2-isocyanatomalonate esters and a Mg-
BOX complex as catalyst (Scheme 2). 
 
Scheme 1. Formal [3+2] cycloadditions 
 
Scheme 2. Formal [3+2] cycloaddition between 2-isocyanatomalonates and 
unsaturated imines, and ligands used in this study. 
We initially investigated the activity of the LaIII-pyBOX1, CaII-
pyBOX1 and MgII-BOX1 complexes in the reaction between 
diethyl 2-isocyanatomalonate (1) and imine 4a derived from o-
anisidine (Table 1, entries 1-3).[24] In all the cases, the reaction 
proceeded smoothly to give pyrrolidinone 5a, which features a 
conjugated exocyclic double, a structural moiety that is present 
in a large number of antitumor compounds. Compound 5a was 
obtained as a single geometric isomer having the Z configuration 
at the double bond. Regarding enantioselectivity, the LaIII-
pyBOX1 complex gave compound 5a in almost racemic form, 
while the CaII-pyBOX1 and MgII-BOX1 complexes showed 
similar enantioselectivities (ee = 67%), although the magnesium 
complex seemed slightly more active. Further research was 
continued by testing several Mg-BOX complexes. The best 
result was obtained with BOX6 that provided compound 5a in 
98% yield with 71% ee (Table 1, entry 8). A decrease of 
temperature to 0 °C increased the ee up to 80%, however 
further decrease of temperature to -20 °C produced a dramatic 
drop of enantioselectivity (Table 1, entries 9 and 10). With the 
optimal temperature (0 °C), the effect of the alcoxy group in the 
2-isocyanatomalonate ester was tested (Table 1, entries 9, 11 
and 12).  
 
Table 1. Enantioselective [3+2] cycloaddition of isocyanatomalonate esters 
with unsaturated imine 2a. Optimization of reaction conditions.[a] 




1 La(OTf)3 pyBOX1 CH2Cl2 Et 25 3 81 3 
2 Ca(OTf)2 pyBOX1 CH2Cl2 Et 25 3.5 89 -67 
3 Mg(OTf)2 BOX1 CH2Cl2 Et 25 2 97 -67 
4 Mg(OTf)2 BOX2 CH2Cl2 Et 25 2.5 83 -5 
5 Mg(OTf)2 BOX3 CH2Cl2 Et 25 2.5 89 -5 
6 Mg(OTf)2 BOX4 CH2Cl2 Et 25 3 94 63 
7 Mg(OTf)2 BOX5 CH2Cl2 Et 25 3 97 29 
8 Mg(OTf)2 BOX6 CH2Cl2 Et 25 2.5 97 71 
9 Mg(OTf)2 BOX6 CH2Cl2 Et 0  3 96 80 
10 Mg(OTf)2 BOX6 CH2Cl2 Et -20  45 68 43 
11 Mg(OTf)2 BOX6 CH2Cl2 Me 0 2 98 49 
12 Mg(OTf)2 BOX6 CH2Cl2 iPr 0 2 98 89 
13 Mg(OTf)2 BOX6 (ClCH2)2 iPr 0 2.5 98 76 
14 Mg(OTf)2 BOX6 CHCl3 iPr 0 2.5 89 91 
15 Mg(OTf)2 BOX6 Et2O iPr 0 2.5 96 91 
16 Mg(OTf)2 BOX7 Et2O iPr 0 1.5 97 97 
[a] Reaction conditions: 1-3 (0.19 mmol), 4a (0.125 mmol, C=N geometry 
isomer mixture), L (0.0125 mmol, M(OTf)2 (0.0125 mmol), 4Å MS (110 mg), 
solvent (1.1 mL). [b] Yield of isolated product. [c] Determined by HPLC with 
chiral stationary phases; opposite sign indicates opposite enantiomers.  
 





It was found that the diisopropyl ester 3 underwent a more 
enantioselective reaction than diethyl or dimethyl 2-
isocyanatomalonates, giving lactam 7a in 98% yield with 89% ee. 
Next, the effect of the solvent was checked. The use of diethyl 
ether as the solvent in the addition of 3 to 4a allowed increasing 
the ee of compound 7a up to 91% (Table 1, entry 15). Finally, in 
view of the important effect of the substitution at the central 
carbon of the BOX ligand on the enantioselectivity of the 
reaction (Table 1, entry 7 vs entry 8), the cyclopropylic BOX7 
ligand was prepared and tested providing compound 7a in 
excellent 97% yield and 97% ee (Table 1, entry 16). 
[a] Reaction conditions: 1-3 (0.19 mmol), 4 (0.125 mmol), BOX7 (0.0125 
mmol, Mg(OTf)2 (0.0125 mmol), 4Å MS (110 mg), Et2O (1.1 mL), 0 °C. [b] 
Yield of isolated product. [c] Determined by HPLC with chiral stationary 
phases. [d] Obtained as a ca. 1:1 mixture of Z/E isomers. [e] Determined after 
enamine hydrolysis. [d] Reaction carried out with 1.6 mmol of 4a. 
With the best conditions available the scope of the reaction 
of diisopropyl 2-isocyanatomalonate (3) and α,β-unsaturated N-
(o-methoxyphenyl)imines 4[25] using the Mg(OTf)2-BOX7 
complex as catalyst was studied. The results are gathered in 
Table 2. The reaction can be carried out with imines bearing at 
the  carbon an aromatic ring substituted with either electron-
withdrawing (Table 2, entries 2 and 3) or electron-donating 
groups (Table 2, entry 4), to give the expected products 7b-d 
with excellent yields and enantioselectivities. R1 can be also a 
heterocyclic furanyl ring (Table 2, entry 5). In this case, 
compound 7e was obtained in almost quantitative yield and 
slightly lower ee (88%). The introduction of a bulky tert-butyl 
group at the β-carbon brought about a decrease on the reaction 
rate and the expected lactam 7f was obtained with low yield and 
enantioselectivity (Table 2, entry 6).  
The R2 group attached to the azomethinic carbon was also 
amenable to variation (Table 2, entries 7-14). Aromatic rings 
bearing either electron-withdrawing or electron-donating groups 
were permitted without showing much influence on the 
enantioselectivity of the reaction. Again, when R2 was a 2-
furanyl group, compound 7m was obtained with lower ee, 
although with high yield (Table 2, entry 13). A naphthyl group 
attached to the imine was also tolerated, compound 7n being 
obtained in 98% yield and 98% ee (Table 2, entry 14). As 
anticipated, diethyl and dimethyl 2-isocyanatomalonates reacted 
with 4a to give the expected lactams with lower 
enantioselectivity than diisopropyl 2-isocyanatomalonate (Table 
2, entries 15 and 16).  To further demonstrate the practicality of 
this newly developed procedure, the reaction of 3 and 4a was 
carried out on a 1.6 mmol scale (500 mg). Product 7a was 
obtained in 96% yield with minimal erosion in the 
enantioselectivity (94% ee, Table 2, entry 17).  
In all the examples studied except with imines 4k and 4l, 
which have an o-substituted phenyl ring attached to the 
azomethinic carbon, compounds 5-7 were obtained as a single 
diastereomer. Compound 7b (Table 2, entry 2) could be 
crystallized and subjected to X-ray analysis,[26] what allowed to 
stablish  the geometry of the enamine double bond as Z and the 
configuration of the stereogenic center as R (Figure 2). The 
absolute stereochemistry of all compounds 5-7 was assigned by 
analogy upon the assumption of a uniform stereochemical 
pathway. 
 
Figure 2. Ortep plot for the X-ray structure of compound 7b. The thermal 
ellipsoids are drawn at the 50% probability level. Flack parameter -0.16(8) 
Table 2. Enantioselective [3+2] cycloaddition of 2-isocyanatomalonate esters 
with unsaturated imines 2. Scope of the reaction.[a] 
 
Entry R R1 R2 t[h] 5-7 Yield [%][b] ee [%][c] 
1 iPr Ph Ph 1.5 7a 97 97 
2 iPr p-ClC6H4 Ph 1.5 7b 93 96 
3 iPr p-NO2C6H4 Ph 1.5 7c 98 98 
4 iPr p-MeOC6H4 Ph 1.5 7d 98 96 
5 iPr 2-furanyl Ph 1 7e 98 88 
6 iPr tBu Ph 20 7f 26 23 
7 iPr Ph p-ClC6H4 1.5 7g 94 99 
8 iPr Ph p-NO2C6H4 1 7h 98 95 
9 iPr Ph p-MeOC6H4 1 7i 97 98 
10 iPr Ph m-NO2C6H4 3 7j 87 97 
11 iPr Ph o-ClC6H4 1.5 7k 98[d] 98[e] 
12 iPr Ph o-NO2C6H4 27 7l 98[d] 99 
13 iPr Ph 2-furanyl 1 7m 98 83 
14 iPr Ph 2-naphthyl 1 7n 98 98 
15 Et Ph Ph 1 5a 96 77 
16 Me Ph Ph 1 6a 97 76 
17[f] iPr Ph Ph 1.5 7a 96 94 
 





Some transformations were carried out on compound 7a 
(Scheme 3). Thus, aqueous hydrolysis of the enamine with 
concentrated HCl in THF gave ketone 8a in 90% yield. On the 
other hand, treatment of 3a with NaBH3CN-AcOH in EtOH 
provided a major amine 9a[26] in 75% yield, together with an 
isomeric amine 9a', whose stereochemistry could not be 
assigned, in 11% yield. Also, the chemoselective  
transesterification of the diisopropyl ester 7a to give the mixed 
diester 10a was efficiently achieved in 89% yield by treatment 
with NaOMe/MeOH. Finally, the pyroglutamic acid derivative 11a 
was obtained in 87% yield after hydrolysis/decarboxylation upon 
treatment of 7a with an excess of tetraethylammonium 
hydroxyde in DMSO at 80 °C. All these reactions took place 
without noticeable loss of enantiomeric excess with respect to 
starting 7a. 
 
Scheme 3. Ar = o-MeOC6H4. i: HCl, THF, rt, 8a: 90%. ii: NaBH3CN, AcOH, 
EtOH, 0 °C, 9a: 75%, 9a' (a diasteromer of 9a):11%. iii: NaOMe/MeOH, 65 °C, 
10a: 89%. iv: Et4NOH, DMSO, 80 °C, 11a: 87%. 
A simplified mechanistic proposal for the [3+2] cycloaddition 
is outlined in Scheme 4. Thus, initial coordination of both 
reaction partners to the MgII-BOX complex would bring about 
nucleophilic activation of the malonate ester via enolization 
together with electrophilic activation of the imine (intermediate I). 
Conjugate addition would lead to enamine intermediate II which 
would undergo nucleophilic addition to the isocyanate group 
giving lactam III. Finally, imine/enamine tautomerization and 
decoordination would give the final products and release the 
catalyst. 
In summary, we have reported the first enantioselective 
formal [3+2] cycloaddition of 2-isocyanatomalonate esters with 
electrophilic alkenes. Using a Mg(OTf)2-BOX complex as 
catalyst, diisopropyl isocyanatomalonate reacted with α,β-
unsaturated N-(o-anisidyl) imines to give highly substituted chiral 
pyrrolidinones featuring a conjugate exocyclic double bond. The 
reaction products, which are derivatives of pyroglutamic acid, 
were obtained with excellent yields and high to excellent 
enantioselectivities, for a significative number of unsaturated 
imines. The use of the N-(o-anisidyl) group was essential for the 
success of the reaction as neither the unsaturated ketone nor 
the unsaturated N-tosyl imine were reactive with this catalyst. 
Furthermore, the reaction does not requires the use of 
diastereomerically pure imines, instead mixtures of C=N 
geometric isomers can be used. The application of 
nonexpensive and nontoxic Mg(II) salts as Lewis acids is 
another advantage of this procedure. We believe that this 
reaction will open new possibilities for the potential application of 
isocyanato esters as formal 1,3-dipoles in asymmetric catalytic 
reactions. Research toward this goal is currently under progress 
in our laboratory 
 
Scheme 4. Simplified mechanistic proposal for the [3+2] cycloaddition. Mg* = 
Mg-BOX 
Experimental Section 
General procedure for the formal [3+2] reaction: Mg(OTf)2 (4.0 mg, 
0.0125 mmol) was dried in a Schlenk tube under vacuum. BOX7 (6.1 mg, 
0.0125 mmol) was introduced and the Schlenk tube was filled with 
nitrogen. Et2O (0.55 mL) was added via syringe and the mixture was 
stirred for 30 min. The tube was introduced in a bath at 0 °C, 4 Å MS 
(110 mg) was then added followed by the imine (0.125 mmol) dissolved 
in dry Et2O (0.5 mL), and by diisopropyl 2-isocyanatomalonate (37 L, 
0.19 mmol). The mixture was stirred at 0 ºC for the indicated time and 
chromatographed on silica gel eluting with hexane/EtOAc mixtures to 
give compounds 7. Compounds 5 and 6 were prepared following the 
same procedure using diethyl or dimethyl 2-isocyanatomalonate, 
respectively. 
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The first asymmetric formal [3+2] cycloaddition involving 2-isocyanato esters and 
electrophilic alkenes is reported. Diisopropyl 2-isocyanatomalonate reacts with α,β-
unsaturated N-(o-anisidyl) imines in the presence of a Mg(OTf)2-BOX complex to 
give highly substituted chiral pyrrolidinones with excellent yields and enantiomeric 
excesses up to 99%. 
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